Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
about
The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisRole of oats in celiac diseasePrecursor-Directed Combinatorial Biosynthesis of Cinnamoyl, Dihydrocinnamoyl, and Benzoyl Anthranilates in Saccharomyces cerevisiaeThe spectrum of major seed storage genes and proteins in oats (Avena sativa).Dietary fiber and satiety: the effects of oats on satiety.Production of hydroxycinnamoyl anthranilates from glucose in Escherichia coliAn evidence-based systematic review of beta-glucan by the natural standard research collaboration.Identification and molecular characterization of oat peptides implicated on coeliac immune response.Whole grain oats, more than just a fiber: Role of unique phytochemicals.Whole grain oats improve insulin sensitivity and plasma cholesterol profile and modify gut microbiota composition in C57BL/6J mice.Compositional Analysis of Whole Grains, Processed Grains, Grain Co-Products, and Other Carbohydrate Sources with Applicability to Pet Animal NutritionUse of lipid-lowering medicinal herbs during pregnancy: A systematic review on safety and dosage.The starch-bound alpha-amylase/trypsin-inhibitors in Avena.The effect of mechanical processing on avenanthramide and phenol levels in two organically grown Italian oat cultivars.Safety evaluation of an oat grain alkaloid gramine by genotoxicity assays.Oats, more than just a whole grain: an introduction.Chromatographic Methods to Evaluate Nutritional Quality in Oat.Synthesis of avenanthramides using engineered Escherichia coli.
P2860
Q26774192-01E08837-8CA7-4591-9D7E-0F7349F93F89Q26777998-4B6AAFA2-F2EE-4EC6-9862-A30FB6562D5FQ28548700-551E2CC8-D1E3-4698-AC39-0AC9EF762975Q35211607-C00A6581-6FEF-4B3B-A958-7FC4CC10AD95Q36591661-216C625E-C147-4844-917D-32A4BE850D37Q37028313-33A05D20-90FC-4DB4-885E-5BD7A53027B6Q38264166-3AB3FCEA-0FE1-46EA-8E30-C1A568E88DC1Q38279890-F3C97030-4E45-45C1-8790-88344D16DA24Q39076307-251EDCAF-4999-4175-8E0B-778806C82DCFQ41491230-E76E8FDE-F086-4CBE-A643-2A3D6D13B727Q42230246-F40058E4-AA92-4810-A667-56A25CC564AEQ45711173-4FF2357A-08CA-463E-B9A1-57F4912637C5Q46471337-94117CCA-3BB7-4DD2-8389-AFEEE3C39839Q48032135-EDE5FCDE-547A-4733-BAD4-44135DDDD7CAQ48122215-6D5F273C-F916-4B8E-95E4-941BCF446D12Q48710271-E0F2BAF7-E692-4CD4-B94E-5D077928A8E7Q51164211-E885C80D-91E4-4036-9EDA-6E02D876482EQ52642408-19CEB432-A7BB-4A0D-BF95-244D447DF913
P2860
Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
@en
type
label
Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
@en
prefLabel
Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
@en
P2093
P2860
P1476
Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview.
@en
P2093
Asma Belkheir
Rajinder Singh
Subrata De
P2860
P304
P356
10.1080/10408398.2010.526725
P577
2013-01-01T00:00:00Z